These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28820747)

  • 41. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.
    Diaz-Ricart M; Palomo M; Fuste B; Lopez-Vilchez I; Carbo C; Perez-Pujol S; White JG; Escolar G
    Thromb Res; 2008; 121(6):873-83. PubMed ID: 17904203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects.
    Vaidyula VR; Boden G; Rao AK
    Platelets; 2006 Dec; 17(8):577-85. PubMed ID: 17127486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.
    Connor DE; Ly K; Aslam A; Boland J; Low J; Jarvis S; Muller DW; Joseph JE
    Platelets; 2016 Dec; 27(8):805-811. PubMed ID: 27310292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The changes in protein content and procoagulantory activity of platelet-associated tissue factor in thrombotic diseases].
    Huang XL; Chen FP; Du JW; Yu BJ; Hu J; Deng MX
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):585-7. PubMed ID: 16194410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation.
    Munnix IC; Kuijpers MJ; Auger J; Thomassen CM; Panizzi P; van Zandvoort MA; Rosing J; Bock PE; Watson SP; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2484-90. PubMed ID: 17761939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Factors influencing platelet procoagulant activity in type II diabetic patients. The role of sodium-proton exchange].
    Telejko B; Kinalska I; Stelmach H; Tomasiak M
    Przegl Lek; 2003; 60(9):553-6. PubMed ID: 15065331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperglycemia exacerbates ischemic stroke outcome independent of platelet glucose uptake.
    Denorme F; Portier I; Kosaka Y; Campbell RA
    J Thromb Haemost; 2021 Feb; 19(2):536-546. PubMed ID: 33118271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disorders of haemostasis in diabetes mellitus.
    Preston FE
    Ric Clin Lab; 1982; 12(3):425-38. PubMed ID: 7134747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A tip of the cap to procoagulant platelets.
    Storrie B
    Blood; 2016 Sep; 128(13):1668-9. PubMed ID: 27688780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects.
    Ceriello A
    Diabetologia; 1993 Nov; 36(11):1119-25. PubMed ID: 8270125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plant-derived compounds normalize platelet bioenergetics and function in hyperglycemia.
    Gauer JS; Ajanel A; Kaselampao LM; Candir I; MacCannell ADV; Roberts LD; Campbell RA; Ariëns RAS
    Res Pract Thromb Haemost; 2024 Aug; 8(6):102548. PubMed ID: 39309231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet aggregation and thrombus formation in Diabetes Mellitus: an in vitro study.
    Rathbone RL; Ardlie NG; Schwartz CJ
    Pathology; 1970 Oct; 2(4):307-16. PubMed ID: 5520775
    [No Abstract]   [Full Text] [Related]  

  • 54. In Vitro Exposure to Glucose Alters the Expression of Phosphorylated Proteins in Platelets.
    Suzuki M; Takeshita K; Kitamura Y; Kuribayashi M; Huang Z; Ichihara G; Oikawa S; Ichihara S
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of platelet-derived microparticles in patients with diabetes.
    Nomura S; Miyazaki Y; Miyake T; Suzuki M; Kawakatsu T; Kido H; Yamaguchi K; Fukuroi T; Kagawa H; Yanabu M
    Am J Hematol; 1993 Nov; 44(3):213. PubMed ID: 8213778
    [No Abstract]   [Full Text] [Related]  

  • 56. Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets.
    Aliotta A; Bertaggia Calderara D; Zermatten MG; Marchetti M; Alberio L
    J Clin Med; 2021 Feb; 10(5):. PubMed ID: 33668091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet count neither decreases nor relates to blood glucose level.
    Soogarun S; Wiwanitkit V; Suwansaksri J
    Clin Appl Thromb Hemost; 2004 Apr; 10(2):187-8. PubMed ID: 15094941
    [No Abstract]   [Full Text] [Related]  

  • 58. Normal range of mean platelet volume in healthy subjects.
    Varol E
    Thromb Res; 2011 Nov; 128(5):496; author reply 497. PubMed ID: 21813163
    [No Abstract]   [Full Text] [Related]  

  • 59. Reference range of mean platelet volume.
    Hoffmann JJ
    Thromb Res; 2012 Apr; 129(4):534-5. PubMed ID: 22123584
    [No Abstract]   [Full Text] [Related]  

  • 60. Proteomic analysis of plasma total exosomes and placenta-derived exosomes in patients with gestational diabetes mellitus in the first and second trimesters.
    Lin J; Zhao D; Liang Y; Liang Z; Wang M; Tang X; Zhuang H; Wang H; Yin X; Huang Y; Yin L; Shen L
    BMC Pregnancy Childbirth; 2024 Oct; 24(1):713. PubMed ID: 39478498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.